Clinical Trial Update: Comparison of a Long-acting Injectable Antipsychotic vs Clinician's Choice Early in Treatment to Break the Cycle of Relapse in Early Phase Schizophrenics [Phase 4]

View source ↗

Summary

Phase 4 trial comparing a long-acting injectable antipsychotic to clinician's choice early in treatment for schizophrenia; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Snippet

Sponsor: Vanguard Research Group | Conditions: Schizophrenia | Phase 4 | Status: COMPLETED | Results posted: 2020-11-17